Healthcare policies have rapidly evolved in recent years, and 2025 was no exception. From payment policies to physician shortages, ASE and other medical societies had plenty to fight for throughout the year.

As IR procedure volumes continue to climb, coupled with anesthesiology provider shortages, there is growing interest in achieving “deeper, more reliable sedation.” 

The group was recently asked to provide input on a new set of recommendations for image-guided biopsies of suspicious breast lesions—offering providers clarity on key clinical scenarios.

The decision to utilize such scans is challenging for emergency providers, with the condition most often of benign origin, according to new research published in the journal of Emergency Radiology. 

Ferumoxytol is used primarily in medications that treat anemia, but the FDA recently cleared it for deployment in brain imaging as well.

The tool also can be used on contrasted abdominal scans completed for other clinical indications, addressing suspicious lesions before they worsen.  

“Physical AI agents being able to actually deliver some of these services—all the way into robotic surgery—this is where we're going to see this next chapter of medicine be written,” said Kimberly Powell, vice president and general manager of healthcare at Nvidia.
 

The Soft-Tissue Tumor Reporting and Data System (ST-RADS) is an MRI framework that was designed to assess the risk of soft tissue tumors and help providers in managing the finding.